As part of its advocacy program in the United States, ACRO submits regulatory comments to US regulators. This comment letter, submitted by ACRO to FDA in 2014 about Informed Consent Information Sheet: Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors – Draft Guidance can be found below.